Dalvie, Shareefa http://orcid.org/0000-0003-2333-4823
Maihofer, Adam X. http://orcid.org/0000-0003-4517-1623
Coleman, Jonathan R. I. http://orcid.org/0000-0002-6759-0944
Bradley, Bekh
Breen, Gerome
Brick, Leslie A.
Chen, Chia-Yen http://orcid.org/0000-0001-9548-5597
Choi, Karmel W.
Duncan, Laramie E. http://orcid.org/0000-0003-1131-661X
Guffanti, Guia
Haas, Magali http://orcid.org/0000-0002-6611-2449
Harnal, Supriya
Liberzon, Israel
Nugent, Nicole R.
Provost, Allison C.
Ressler, Kerry J.
Torres, Katy http://orcid.org/0000-0003-4201-0349
Amstadter, Ananda B.
Bryn Austin, S.
Baker, Dewleen G. http://orcid.org/0000-0002-1736-9838
Bolger, Elizabeth A.
Bryant, Richard A. http://orcid.org/0000-0002-9607-819X
Calabrese, Joseph R.
Delahanty, Douglas L.
Farrer, Lindsay A.
Feeny, Norah C. http://orcid.org/0000-0001-8590-4591
Flory, Janine D.
Forbes, David
Galea, Sandro
Gautam, Aarti
Gelernter, Joel http://orcid.org/0000-0002-4067-1859
Hammamieh, Rasha
Jett, Marti http://orcid.org/0000-0002-2899-0216
Junglen, Angela G.
Kaufman, Milissa L.
Kessler, Ronald C. http://orcid.org/0000-0003-4831-2305
Khan, Alaptagin
Kranzler, Henry R.
Lebois, Lauren A. M. http://orcid.org/0000-0001-5816-9181
Marmar, Charles
Mavissakalian, Matig R.
McFarlane, Alexander
Donnell, Meaghan O’
Orcutt, Holly K.
Pietrzak, Robert H.
Risbrough, Victoria B. http://orcid.org/0000-0001-8347-3820
Roberts, Andrea L. http://orcid.org/0000-0001-5023-4399
Rothbaum, Alex O.
Roy-Byrne, Peter
Ruggiero, Ken
Seligowski, Antonia V.
Sheerin, Christina M. http://orcid.org/0000-0003-3773-641X
Silove, Derrick
Smoller, Jordan W. http://orcid.org/0000-0002-0381-6334
Stein, Murray B. http://orcid.org/0000-0001-9564-2871
Teicher, Martin H.
Ursano, Robert J.
Van Hooff, Miranda
Winternitz, Sherry
Wolff, Jonathan D.
Yehuda, Rachel
Zhao, Hongyu
Zoellner, Lori A.
Stein, Dan J. http://orcid.org/0000-0001-7218-7810
Koenen, Karestan C.
Nievergelt, Caroline M. http://orcid.org/0000-0001-5766-8923
Article History
Received: 3 August 2019
Revised: 28 November 2019
Accepted: 11 December 2019
First Online: 27 January 2020
Conflict of interest
: H.R.K. is a member of the American Society of Clinical Psychopharmacology’s Alcohol Clinical Trials Initiative (ACTIVE), which in the last 3 years was supported by AbbVie, Alkermes, Amygdala Neurosciences, Arbor, Ethypharm, Indivior, Lilly, Lundbeck, Otsuka, and Pfizer. H.R.K. and J.G. are named as inventors on PCT patent application #15/878,640 entitled: “Genotype-guided dosing of opioid agonists,” filed January 24, 2018. In the past 3 years, D.J.S. has received research grants and/or consultancy honoraria from Lundbeck and Sun. In the past 3 years, R.C.K. received support for his epidemiological studies from Sanofi Aventis; was a consultant for Johnson & Johnson Wellness and Prevention, Sage Pharmaceuticals, Shire, Takeda; and served on an advisory board for the Johnson & Johnson. Services Inc. Lake Nona Life Project. Kessler is a co-owner of DataStat, Inc., a market research firm that carries out healthcare research. M.B.S. has in the past 3 years been a consultant for Aptinyx, Bionomics, Dart Neuroscience, Janssen, Jazz Pharmaceuticals, Neurocrine Biosciences, Oxeia Biopharmaceuticals, and Pfizer. R.Y. is a co-inventor of the following patent application: “Genes associated with posttraumatic-stress disorder. European Patent# EP 2334816 B1.